To remain competitive and to take advantage of the latest innovations, life science companies can’t afford to ignore opportunities in South Korea.

PharmaVentures has successfully completed over 30 projects for South Korean biotechs and pharma companies over the last 5 years and is recognised as a leading western transaction advisory firm in the region.

In this white paper, we look at the significant innovative drug development that has taken place within South Korea during the last decade, and how we can use our experience in this area to help Western pharma and biotech companies meet their pipeline needs by accessing the companies at the cutting edge of our industry.

How South Korea is an exciting prospect for the world’s life sciences industry

Download Request